According to the Washington Post, the Food and Drug Administration (FDA) has approved the first alternative to the Pap test as a primary screening method for cervical cancer, in the face of opposition from some women’s groups and health organizations. The new test, developed by Roche, detects the DNA of the human papilloma virus, which […]